CHRU Lille - Hopital Claude Huriez /ID# 211829

Lille, Hauts-de-France 59037

0 studies enrolling now · 1 studies all time

What they study most

Systemic Lupus Erythematosus (SLE)

Studies at this site

• A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) — Completed